Page last updated: 2024-09-05

varenicline and Body Weight

varenicline has been researched along with Body Weight in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cornuz, J; Csajka, C; Dobrinas, M; Eap, CB; Glatard, A; Guidi, M1
Kanaoka, Y; Kataoka, Y; Koga, M; Kubo, N; Ohishi, K; Ohkido, Y; Sugiyama, K; Yamauchi, A1
Faessel, H; Ravva, P; Williams, K1
Mikkelsen, K; Tønnesen, P1

Trials

3 trial(s) available for varenicline and Body Weight

ArticleYear
Influence of body weight and UGT2B7 polymorphism on varenicline exposure in a cohort of smokers from the general population.
    European journal of clinical pharmacology, 2019, Volume: 75, Issue:7

    Topics: Adult; Body Weight; Carbon Monoxide; Dose-Response Relationship, Drug; Female; Genotype; Glucuronosyltransferase; Humans; Male; Middle Aged; Models, Biological; Polymorphism, Single Nucleotide; Smokers; Smoking Cessation; Smoking Cessation Agents; Varenicline; Young Adult

2019
Pharmacokinetics, safety, and tolerability of varenicline in healthy adolescent smokers: a multicenter, randomized, double-blind, placebo-controlled, parallel-group study.
    Clinical therapeutics, 2009, Volume: 31, Issue:1

    Topics: Adolescent; Area Under Curve; Benzazepines; Body Weight; Child; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Nicotinic Agonists; Nonlinear Dynamics; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Tissue Distribution; Treatment Outcome; Varenicline

2009
Varenicline to stop long-term nicotine replacement use: a double-blind, randomized, placebo-controlled trial.
    Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2013, Volume: 15, Issue:2

    Topics: Benzazepines; Body Weight; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Antagonists; Placebos; Quinoxalines; Smoking Cessation; Substance Withdrawal Syndrome; Surveys and Questionnaires; Varenicline

2013

Other Studies

1 other study(ies) available for varenicline and Body Weight

ArticleYear
Varenicline aggravates plaque formation through α7 nicotinic acetylcholine receptors in ApoE KO mice.
    Biochemical and biophysical research communications, 2014, Dec-12, Volume: 455, Issue:3-4

    Topics: Aconitine; alpha7 Nicotinic Acetylcholine Receptor; Animals; Apolipoproteins E; Benzazepines; Body Weight; Cardiovascular Diseases; Cholesterol; Disease Models, Animal; Mice; Mice, Inbred C57BL; Mice, Knockout; Nicotinic Agonists; Plaque, Atherosclerotic; Quinoxalines; Varenicline

2014